Friday, September 10, 2021 2:36:41 PM
Looks like the FDA was never interested at all in repurposed drugs or alternate solutions for Treatments except a Big Pharma's like Gilead's Rem (Wuhan V I).
Moving on with Ifenprodil to a Phase 3 wasn't going to work for us, or for any treatment drugs.
Reread the Rem data and compare it to Ifenprodil, O2/IL-6/time on ventilators. Maybe AGN could find an interested partner for ARDS or other lung disease treatments.
But the intentions for COVID in the FDA are clear, Big Pharma Vaccines or Treatments ONLY... Some of the top folks that approved the vaccines have already taken jobs at these BPs...Sad...
https://finance.yahoo.com/news/1-u-fda-may-authorize-162334334.html
Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM
Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • SONGD • May 17, 2024 11:00 AM
VPR Brands (VPRB) Reports First Quarter 2024 Financial Results • VPRB • May 17, 2024 8:04 AM
ILUS Provides a First Quarter Filing Update • ILUS • May 16, 2024 11:26 AM
Cannabix Technologies and Omega Laboratories Inc. enter Strategic Partnership to Commercialize Marijuana Breathalyzer Technology • BLO • May 16, 2024 8:13 AM
Avant Technologies to Revolutionize Data Center Management with Proprietary AI Software Platform • AVAI • May 16, 2024 8:00 AM